Physician profile
Philip Schertz
NPI 1730618471
$1,907.67
in general payments reported to CMS, 2019-2025
12 companies · $1,182 in 2025
The $1,182 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2023: $357 · 2024: $157 · 2025: $1,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $440.68 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Spyglass Discover, General - Vascular Intervention |
| Stryker Corporation | $319.64 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Sirtex Medical INC | $274.13 | 2023-2025 | Sir-Spheres Microspheres |
| Medtronic, INC. | $219.17 | 2023 | Kyphon Express II Kyphopak Tray, Concertotm, Abre |
| Imperative Care, INC | $202.64 | 2025 | Symphony Catheter, Truvic Generator |
| Bard Peripheral Vascular, INC. | $157.22 | 2024 | Lutonix Drug Coated Balloon |
| Endogastric Solutions, INC | $110.36 | 2019 | |
| Allergan, INC. | $72.40 | 2019 | |
| Becton, Dickinson and Company | $36.45 | 2025 | Pleurx, Liverty |
| Intuitive Surgical, INC. | $29.20 | 2019 | |
| Ethicon US, LLC | $25.03 | 2025 | Neuwave |
| Ambu INC. | $20.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Schertz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.